XML 34 R24.htm IDEA: XBRL DOCUMENT v3.21.1
Restructuring Expenses
3 Months Ended
Mar. 31, 2021
Restructuring and Related Activities [Abstract]  
Restructuring Expenses Restructuring Expenses
During 2020, the Company announced a company-wide organizational realignment initiative in order to more effectively align its organizational infrastructure and operations with the strategic vision of the autonomous pharmacy. In the first quarter of 2021, the Company continued its organizational realignment initiative. During the three months ended March 31, 2021 and 2020, the Company incurred $2.0 million and $3.6 million of employee severance costs and related expenses, respectively. As of March 31, 2021, the unpaid balance related to this restructuring plan was $1.2 million.
The following table summarizes the total restructuring expense recognized in the Company’s Condensed Consolidated Statements of Operations for the three months ended March 31, 2021 and 2020:
Three Months Ended March 31,
20212020
(In thousands)
Cost of product and service revenues$389 $75 
Research and development105 798 
Selling, general, and administrative1,526 2,732 
Total restructuring expense$2,020 $3,605